This is the last issue of The Journal of Immunology to contain a Clinical Immunology section jointly sponsored by the American Association of Immunologists and the Clinical Immunology Society. Since July 1992, the two organizations have sponsored this section, but this effort is ending because the Clinical Immunology Society has decided to publish its own journal named Clinical Immunology.
However, The Journal of Immunology will continue to have a section devoted to Clinical Immunology, as there has been since 1976 when the section was first introduced. The intent for this section, as for all other sections of The Journal of Immunology, as stated in The Editorial Policies and Practices, is to "publish novel results in all areas of experimental immunology. Major criteria for acceptance are scientific quality, originality, and conciseness. Descriptions of new reagents, research techniques, or clinical case reports usually are appropriate only to the extent that they provide novel insights into unresolved problems or represent major breakthroughs." We continue to welcome those articles written on clinical topics that have particular relevance to the field of immunology in general.
We wish the Clinical Immunology Society well in their new endeavor.
